Leading Biopharmaceutical Technology Surges Over 240% Intraday After Announcing Plans to Acquire Full Equity of Conflux
Odaily Planet Daily reported that Hong Kong-listed company Leading Pharma-Biotech (00399) saw a surge in trading volume and a sharp rise in its share price during early trading today, with an intraday increase of nearly 240% and a peak price of HK$0.7, before retreating to around HK$0.34.
Previously, the company announced plans to acquire all equity in the blockchain project Conflux to expand its presence in the blockchain sector. Two founding members of Conflux currently serve as its executive directors.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
US-listed company Onfolio Holdings secures up to $300 million in funding to build a digital asset treasury
Onfolio Holdings raises $300 million to establish a digital asset treasury
Filecoin launches Onchain Cloud, offering verifiable, on-chain guaranteed cloud services
Ethereum Foundation proposes Ethereum Interop Layer solution to optimize L2 user experience
Trending news
MoreCrypto prices
More
